Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

RIZZO, Manfredi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.817
EU - Europa 8.100
AS - Asia 2.955
AF - Africa 84
SA - Sud America 31
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 17
Totale 32.025
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.768
IT - Italia 3.066
CN - Cina 1.523
FI - Finlandia 1.246
UA - Ucraina 1.047
SG - Singapore 1.017
DE - Germania 831
GB - Regno Unito 526
IE - Irlanda 406
SE - Svezia 235
RU - Federazione Russa 234
FR - Francia 180
KR - Corea 83
IN - India 78
RO - Romania 76
CI - Costa d'Avorio 67
HK - Hong Kong 59
BE - Belgio 40
IR - Iran 39
CA - Canada 34
CH - Svizzera 31
NL - Olanda 30
GR - Grecia 27
TR - Turchia 25
ES - Italia 19
PL - Polonia 19
LB - Libano 17
AT - Austria 16
JP - Giappone 16
IQ - Iraq 15
UZ - Uzbekistan 13
AU - Australia 12
IL - Israele 12
CZ - Repubblica Ceca 11
EU - Europa 11
HR - Croazia 11
BR - Brasile 10
PK - Pakistan 10
NZ - Nuova Zelanda 9
RS - Serbia 9
BG - Bulgaria 8
ID - Indonesia 8
MX - Messico 8
PH - Filippine 8
VE - Venezuela 8
CL - Cile 7
A2 - ???statistics.table.value.countryCode.A2??? 6
EE - Estonia 5
HU - Ungheria 5
SA - Arabia Saudita 5
TW - Taiwan 5
DZ - Algeria 4
MY - Malesia 4
NO - Norvegia 4
TH - Thailandia 4
VN - Vietnam 4
BA - Bosnia-Erzegovina 3
CO - Colombia 3
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
KE - Kenya 3
SI - Slovenia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
EG - Egitto 2
HN - Honduras 2
KZ - Kazakistan 2
MD - Moldavia 2
PE - Perù 2
PT - Portogallo 2
ZA - Sudafrica 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BD - Bangladesh 1
BO - Bolivia 1
BT - Bhutan 1
BW - Botswana 1
CU - Cuba 1
IM - Isola di Man 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
SM - San Marino 1
UG - Uganda 1
Totale 32.025
Salva come PNG Salva come JPEG
Città #
Fairfield 3.269
Ashburn 1.985
Woodbridge 1.604
Chandler 1.592
Wilmington 1.407
Houston 1.378
Seattle 1.213
Cambridge 1.032
Singapore 776
Ann Arbor 696
Medford 681
Palermo 535
Altamura 441
Princeton 435
Jacksonville 431
Dublin 406
Nanjing 377
Lawrence 291
Des Moines 261
Santa Clara 239
San Diego 235
Dearborn 226
Boardman 206
Tulsa 182
Milan 169
Beijing 140
Ludwigshafen am Rhein 130
Hebei 125
Shenyang 124
Nanchang 112
London 106
New York 92
Changsha 86
Jiaxing 86
Jinan 82
Rome 82
Tianjin 75
Seongnam 73
Abidjan 67
Verona 60
Krefeld 56
Saint Petersburg 56
Los Angeles 54
Zhengzhou 49
Ningbo 47
San Paolo di Civitate 45
Orange 43
Auburn Hills 40
Central 38
Frankfurt am Main 38
Munich 38
Falls Church 37
Lappeenranta 37
Helsinki 36
Taizhou 36
Brussels 35
Guangzhou 31
Pune 31
Venice 30
Nuremberg 28
Kilburn 27
Florence 25
Redwood City 25
San Mateo 24
Bremen 23
Norwalk 23
Chicago 22
Grosseto 22
Kumar 22
Moscow 22
Washington 22
Naples 21
Tehran 21
Kunming 19
Phoenix 19
Bologna 18
Hangzhou 17
Dallas 16
Edinburgh 16
Hong Kong 16
Brolo 15
Catania 15
Düsseldorf 15
Hounslow 15
Chiswick 14
Lanzhou 14
Haikou 13
Taiyuan 13
Napoli 12
Turin 12
Bad Bellingen 11
Genoa 11
Parma 11
Zagreb 11
Candelo 10
Hefei 10
Islington 10
Izmir 10
Prescot 10
Den Haag 9
Totale 22.973
Salva come PNG Salva come JPEG
Nome #
LE VESCICOLE EXTRACELLULARI VEGETALI PER LO SVILUPPO DI NUOVI NUTRACEUTICI: STUDIO PRE-CLINICO E CLINICO DELLE PROPRIETÀ BIOLOGICHE DELLE VESCICOLE ISOLATE DA SUCCO DI LIMONE 243
NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet 213
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 189
Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis. 189
Clinical importance of eosinophil count in nasal fluid in patients with allergic and non-allergic rhinitis 179
A NOVEL THERAPEUTIC APPROACH TO COLORECTAL CANCER IN DIABETES: ROLE OF METFORMIN AND RAPAMYCIN 178
Association between COX-2 rs 6681231 genotype and interleukin-6 in periodontal connective tissue. A pilot study. 175
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. 173
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 164
Who needs to care about small, dense low density lipoproteins? 163
Oral manifestations of inflammatory bowel disease 162
Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction 161
Interleukin 6 plasma levels predict with high sensitivity and specificity coronary stenosis detected by coronary angiography 160
Management of Statin Intolerance in 2018: Still More Questions Than Answers 156
Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study 153
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 151
Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity. 149
Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome 149
Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease 148
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 147
Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention. 145
The effect of bergamot on dyslipidemia 145
Statin intolerance - An attempt at a unified definition. Position paper from an International Lipid Expert Panel 145
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. 143
High resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD. 142
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 141
Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions 140
Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. 140
INTERLEUKIN 6 PLASMA LEVELS PREDICT WITH HIGH SENSITIVITY AND SPECIFICITY CORONARY STENOSIS DETECTED BY CORONARY ANGIOGRAPHY 138
ASSOCIATION OF ELEVATED FIBRINOGEN AND C-REACTIVE PROTEIN LEVELS WITH CAROTID LESIONS IN PATIENTS WITH NEWLY DIAGNOSED HYPERTENSION OR TYPE-II DIABETES 137
Heat Shock Protein-60 and Risk for Cardiovascular Disease. 136
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. 135
Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy-A meta-analysis of 11 randomized controlled trials involving 21,295 participants 135
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 135
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 134
Serum low density lipoprotein subclasses in asthma 134
The Role of Nutraceuticals in Statin Intolerant Patients 133
Emerging approaches for the treatment of hypertriglyceridemia. 132
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. 132
Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel 131
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? 129
Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. 129
Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. 128
Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases 128
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 128
Therapeutic patient education in oncology: pedagogical notions for women's health and prevention. 127
Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention? 125
Anti-cytokine therapy for prevention of atherosclerosis 125
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene. 124
Febbre di origine sconosciuta (FUO): due casisitiche di una medesima divisione di medicina interna a confronto 124
ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON) 123
Nutritional characteristics of a rural Southern Italy population: the Ventimiglia di Sicilia Project 123
Periodontitis, blood lipids and lipoproteins. 122
Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis 121
The clinical significance of small, dense low-density lipoproteins 120
The role of fibrate treatment in dyslipidemia: an overview. 120
Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease 120
Resistin: An inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome 120
Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. 119
Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. 119
Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction 119
An update on the relationships between rheumatoid arthritis and atherosclerosis. 119
Differential apolipoprotein(a) isoform expression in heterozygosity is an independent contributor to lipoprotein(a) levels variability 119
Should low high-density lipoprotein cholesterol (HDL-C) be treated? 119
The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates 119
Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions. 118
Atherogenic forms of dyslipidemia in women with polycystic ovary syndrome 118
Cystatin C levels are decreased in acute myocardial infarction: Effect of cystatin C G73A gene polymorphism on plasma levels 118
The atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. 116
New lipid modulating drugs: the role of microsomal transport protein inhibitors. 116
Oxidative stress markers at birth: Analyses of a neonatal population 115
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 115
Uric acid metabolism in pre-hypertension and the metabolic syndrome 114
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. 114
Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes 114
Heat-shock protein 60 kDa and atherogenic dyslipidemia in patients with untreated mild periodontitis: a pilot study. 113
A case of bowel schistosomiasis that did not adhere to the endoscopic findings. 113
SUBFRACTIONS AND SUBPOPULATIONS OF HDL: AN UPDATE 113
The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy -- 5-year follow-up. 112
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 112
Small, dense low-density-lipoproteins and the metabolic syndrome. 111
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study 111
GLP-1 receptor agonists, carotid atherosclerosis and retinopathy 111
Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A. 110
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study 110
Interleukin-18 levels are associated with low-density lipoproteins size. 109
Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol 108
Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia. 108
An evaluation of RVX-208 for the treatment of atherosclerosis 108
A Potential Link between Serum Low-Density Lipoproteins and Asthma 108
Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. 107
Post-prandial alterations in LDL size and subclasses in patients with growth hormone deficiency. 107
In vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parameters 107
The role of small, dense low-density lipoproteins in non-coronary forms of atherosclerosis. 106
PROGNOSTIC IMPACT OF HYPERTENSION AND CAROTID LESIONS IN A FIVE YEARS FOLLOW UP 105
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease 104
ApoE polymorphism in a small Mediterranean island: Relationships with plasma lipids, lipoproteins and LDL particle size 103
Uso degli stent medicati con rapamicina in pazienti con situazioni anatomiche o cliniche che favoriscono la restenosi: risultati del follow-up di 6 mesi su primi 100 pazienti 103
Androgen excess and cardiovascular risk. 102
Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome 102
Totale 13.085
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.631 0 0 0 665 773 1.042 770 513 763 316 523 266
2020/20214.534 174 421 296 724 506 271 261 319 418 407 271 466
2021/20224.358 183 865 72 183 112 126 182 208 489 854 207 877
2022/20235.635 590 1.037 73 461 667 740 262 430 906 59 315 95
2023/20242.852 137 354 191 230 237 712 320 204 71 84 73 239
2024/20251.974 299 719 763 193 0 0 0 0 0 0 0 0
Totale 33.876